Endoglin (CD105) expression in the human heart throughout gestation: An immunohistochemical study

Reproductive Sciences

Volumn 15, Issue 10, 2008, Pages 1018-1026

  Valeria, Barresi ^a,b   Maddalena, Grosso ^a   Enrica, Vitarelli ^a   Onofrio, Triolo ^a   Gaetano, Barresi ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Endoglin; Fetus; Growth defects; Heart; Malformation

Indexed keywords

ENDOGLIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ARTICLE; AUTOPSY; CARDIOVASCULAR SYSTEM; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; ENDOCARDIUM; FETUS; GENE MUTATION; GESTATION PERIOD; GESTATIONAL AGE; HEART DEVELOPMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; AGE; BIOSYNTHESIS; COMPARATIVE STUDY; EMBRYOLOGY; FEMALE; FETUS HEART; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HEART; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY;

AGE FACTORS; ANTIGENS, CD; FEMALE; FETAL HEART; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; PREGNANCY; RECEPTORS, CELL SURFACE;

EID: 57849131816     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108322429     Document Type: Article

References (25)

1. Cheifetz S., Bellon T., Cales C., et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem. 1992 ; 267: 19027-19030.
2. Burrows FJ, Derbyshire EJ, Tazzari PL, et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumours: implications for diagnosis and therapy. Clin Cancer Res. 1995 ; 1: 1623-1634.
3. Miller DW, Graulich W., Karges B., et al. Elevated expression of endoglin, a component of the TGF-ß receptor complex, correlates with proliferation of tumour endothelial cells. Int J Cancer. 1999 ; 81: 568-572.
4. Torsney E., Charlton R., Parums D., Collis D., Arthur HM Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res. 2002 ; 51: 464-470.
5. Barresi V., Cerasoli S., Vitarelli E., Tuccari G. Density of micro-vessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol. 2007 ; 114: 147-156.
6. Wang JM, Kumar S., Pye D., van Aghtoven AJ, Krupinski J., Hunter RD A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer. 1993 ; 54: 363-370.
7. Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science. 1999 ; 284: 1534-1537.
8. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994 ; 8: 345-351.
9. Bourdeau A., Dumont DJ, Letrate M. A murine model of hereditary haemorrhagic telangiectasia. J Clin Invest. 1999 ; 104: 1343-1351.
10. Arthur HM, Ure J., Smith AJ, et al. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol. 2000 ; 217: 42-53.
11. Sorensen LK, Brooke BS, Li DY, Urness LD Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular specific TGFbeta coreceptor. Dev Biol. 2003 ; 261: 235-250.
12. Qu R., Silver MM, Letarte M. Distribution od endoglin in early human development reveals high levels on endocardial tissue cushion mesenchyme during valve formation. Cell Tissue Res. 1998 ; 292: 333-343.
13. Vincent EB, Runyan RB, Weeks DL Production of the transforming growth factor-beta binding protein endoglin is up-regulated during chick heart development. Dev Dyn. 1998 ; 213: 237-247.
14. Bourdeau A., Faughnan ME, Letarte M. Endoglin-deficient mice, a unique model to study hereditary haemorrhagic telangiectasia. Trends Cardiovasc Med. 2000 ; 10: 279-285.
15. Mercado-Pimentel ME, Hubbard AD, Runyan RB Endoglin and Alk5 regulate epithelial-mesenchymal transformation durino cardiac valve formation. Dev Biol. 2007 ; 304: 420-432.
16. Jonker L., Arthur HM Endoglin expression in early development is associated with vasculogenesis and angiogenesis. Mech Dev. 2002 ; 110: 193-196.
17. Barresi V., Grosso M., Vitarelli E., Granese R., Barresi G. Endoglin (CD105) immuno-expression in human foetal and neonatal lung. Histol Histopathol. 2008 ; 23: 701-708.
18. Hansen K., Sung CJ, Huang C., Pinar H., Singer DB, Oyer CE Reference values for second trimester fetal and neonatal organ weights and measurements. Pediatr Dev Pathol. 2003 ; 6: 160-167.
19. Gougos A., St Jacques S., Greaves A., et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol. 1992 ; 4: 83-92.
20. Sandlund J., Hedberg Y., Bergh A., Grankvist K., Ljunberg B., Rasmuson T. Endoglin (CD105) expression in human renal cell carcinoma. BJU Int. 2006 ; 97: 706-710.
21. St-Jacques S., Cymerman U., Pece N., Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. Endocrinology. 1994 ; 134: 2645-2657.
22. Bankl H. Particular malformations. In: Congenital Malformations of the Heart and Great Vessels. Baltimore - Munich: Urban & Schwarzenberg ; 1977: 107-111.
23. Rajakumar A., Jeyabalan A., Markovic N., Ness R., Gilmour C., Conrad KP Placental HIF-1 alpha, HIF-2 alpha, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol. 2007 ; 293: R766 - R774.
24. McCarthy C., Cotter FE, McElwaine S., Twomey A., Mooney EE, Ryan F., Vaughan J. Altered gene expression patterns in intrauterine growth restriction: potential role of hypoxia. Am J Obstet Gynecol. 2007 ; 196: 70.e1 - e6.
25. Treins C., Giorgetti-Peraldi S., Murdaca J., Semenza GL, Van Obberghen E. Insulin stimulates hypoxia-inducible factor1 through a phosphatidylinositol 3-kinase/target of rapamycin dependent signaling pathway. J Biol Chem. 2002 ; 277: 27975-27981.